Subscribe to Newsletter

Bioprocessing - Upstream & Downstream

Manufacture Bioprocessing - Upstream & Downstream

May’s Top Biopharma Headlines

| Stephanie Vine | 3 min read

What happened in May in the biopharma industry? Here’s our roundup of the biggest headlines.

Manufacture Bioprocessing - Upstream & Downstream

Securing Supply: Best Practices for Critical Raw Materials

| Michelle Ferreri | 6 min read

COVID-19 has taught us that unexpected events can cause significant supply chain disruption, so pharma must be prepared.

Manufacture Bioprocessing - Single Use Systems

From Saving Patients to Saving the Planet

| Stephanie Vine | 17 min read

How can pharma help save the environment? We need to use green chemistry, reduce cleanroom sizes, and use less energy.

Business & Regulation Profession

Welcome to the Pharma Party

| Maryam Mahdi

Celebrate the people, companies, and innovations had the biggest impact on pharma in the last year.

Manufacture Bioprocessing - Upstream & Downstream

mAbs: Making the Right Equipment and Process Decisions

| Sponsored by Thermo Fisher Scientific

Matthew Zustiak from Thermo Fisher Scientific discusses the challenges of equipment choice for producing mAbs.

Manufacture Bioprocessing - Upstream & Downstream

Early Scale Up Strategies

| Sponsored by Thermo Fisher Scientific

Efficient and reliable scale up is a key component of mAb production.

Manufacture Bioprocessing - Upstream & Downstream

Enter the Age of Modular Manufacturing

| Sponsored by Thermo Fisher Scientific

Efficient, reliable scale up is a key component of mAb production. Thermo Fisher Scientific’s modularized system provides individual building blocks.

Business & Regulation Business Practice

Celebrating the Pharma Industry’s Most Inspirational People and Companies

The Medicine Maker is proud to present the Power List 2022 and the inaugural Company of the Year Awards

Manufacture Bioprocessing - Upstream & Downstream

The Pandemic Impact: Focusing on Security of Supply in Pharma

| Sponsored by Cytiva

Cytiva is transforming in the wake of COVID-19 – but what lessons can the wider biopharma industry take forward?

Manufacture Bioprocessing - Upstream & Downstream

April’s Top Biopharma Headlines

What happened in April in the biopharma industry? Here’s our roundup of the biggest headlines and research.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register